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Abstract: Proof-of-concept studies that display the potential of using a glucose-sensitive 
hydrogel as a continuous glucose sensor are presented. The swelling ratio, porosity, and 
diffusivity of the hydrogel increased with glucose concentration. In glucose solutions of 
50, 100, 200, and 300 mg/dL, the hydrogel swelling ratios were 4.9, 12.3, 15.9, and 21.7, 
respectively, and the swelling was reversible. The impedance across the hydrogel depended 
solely on the thickness and had an average increase of 47 /mm. The hydrogels exposed to 
a  hyperglycemic  solution  were  more  porous  than  the  hydrogels  exposed  to  a  normal 
glycemic solution. The diffusivity of 390 Da MW fluorescein isothiocyanate in hydrogels 
exposed to normal and hyperglycemic solutions was examined using fluorescence recovery 
after photobleaching and was found to be 9.3 ×  10
−14 and 41.4 ×  10
−14 m
2/s, respectively, 
compared to 6.2 ×  10
−10 m
2/s in glucose solution. There was no significant difference 
between the permeability of hydrogels in normal and hyperglycemic glucose solutions with 
averages being 5.26 ×  10
−17 m
2 and 5.80 ×  10
−17 m
2, respectively, which resembles 2–4% 
agarose  gels.  A  prototype  design  is  presented  for  continuous  intravascular  glucose 
monitoring by attaching a glucose sensor to an FDA-approved stent.  
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1. Introduction 
Diabetes is one of the leading causes of death by disease, killing approximately 3 million people 
around the world and 180,000 Americans each year [1]. Approximately 171 million people worldwide 
are  currently  diagnosed  with  diabetes  and  the  estimated  global  prevalence  is  predicted  to  
be 366 million in 2030 [2]. The number of diagnosed cases has risen by 11% over the last 5 years [3] 
and is expected to double within the next 25 years due to factors such as population growth, increased 
life expectancy, increased prevalence of obesity, and physical inactivity [4]. In the United States diabetes 
costs the healthcare system upwards of $174 billion annually and this number is on the rise [5].  
Diabetes  is  a  manageable  disease;  however  management  requires  accurate  and  frequent 
measurements of a patient’s glucose levels to ensure that they stay within the normal range of 80 to 
110  mg/dL  to  avoid  hypoglycemic  and  hyperglycemic  episodes  [6].  Abnormal  glucose  levels  can 
cause  blood  vessel  damage,  which  in  the long-term  may  result in  adult  blindness,  serious  kidney 
disease, the need for amputations as a result of neuropathy, and a 2–4×  increase in the incidence of 
heart failure [3]. The Diabetes Control and Complications Trial (DCCT) found that tight control of 
glucose levels decreases the occurrence and severity of long-term complications [7]. 
In order to achieve the benefits of tight control, new technology to continuously monitor blood 
glucose levels is being developed with the aim to minimize the pain and effort on the part of the 
patient. There are a few limitations with current continuous glucose monitors: (1) they measure blood 
glucose levels indirectly from the interstitial fluid which lag behind blood glucose levels (2) they can 
only be implanted for short periods of time (3) they are expensive and (4) they are not as accurate as 
blood glucose sensors [8]. To overcome a few of these limitations, we propose to monitor intravascular 
glucose levels continuously using a glucose-sensitive hydrogel embedded in an FDA-approved stent. A 
stent would provide the sensor with constant access to the bloodstream, the mechanical support, and a 
means to transmit data while the stent maintains vessel patency [9]. Importantly, a link has been 
established  between  diabetes  and  heart  failure,  as  the  prevalence  of  diabetes  in  heart  failure 
populations is close to 20% compared to 4–6% in control populations, thus justifying this combined 
technology  [10].  Further,  cardiovascular  disease  has  surpassed  diabetic  neuropathy  as  the  leading 
cause of early death in juvenile type I diabetics [11].  
Recent  research  in  the  field  of  continuous  glucose  monitoring  has  focused  on  developing  
glucose-sensitive  hydrogels.  To  transduce  signal,  the  sensor  designs  exploit  hydrogels  swelling  in 
response  to  chemical  stimuli  [12].  In  this  work,  we  explore  and  characterize  a  
poly(N-isopropylacrylamide)  (PNIPAAm)-based  glucose-sensitive  hydrogel  developed  by  
Kataoka et al. that also contains a phenylboronic acid derivative, which is known to form complexes 
with polyol compounds, like glucose, instead of proteins or enzymes [13,14]. We hypothesized that the 
hydrogel  swelling  would  correlate  to  measureable  impedance  values  that  would  correlate  to 
physiological glucose concentrations. To validate this we investigated mass transport properties and Sensors 2011, 11                                       
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pore size within the hydrogel as well as impedance values after hydrogel swelling. The data suggests 
that the hydrogel holds promise for use as a transducer for continuous glucose monitoring.  
2. Experimental Section  
2.1. Hydrogel Synthesis 
Hydrogel was synthesized with an AAPBA (= 3-acrylamidophenylboronic acid) content of 10 mol % 
as follows: Under argon atmosphere, N-isopropylacrylamide (3.37 g), 3-acrylamidophenylboronic acid 
(0.63 g), and N,N‘-methylene-bis-acrylamide (0.05 g) as a cross-linker were dissolved in 20 mL of 
DMSO  (dimethyl  sulfoxide)  with  initiator  2,2‘-azobis(2,4  dimethylvaleronitrile)  (1  mg/mL).  The 
prepared solution was injected between two Teflon sheets (10 cm ×  10 cm) separated by a Teflon 
gasket  (1.0  mm  thickness)  and  backed  by  glass  plates  and  polymerized  at  60  ° C  for  16  h.  The  
formed hydrogel slab was immersed successively into a series of DMSO/water mixtures (100/0, 75/25,  
50/50, 25/75, and 0/100) to remove unreacted compounds. The slab was kept at least one day in each  
solution [13].  
2.2. Preparation of Glucose Solutions 
Normal physiological blood glucose levels range between 80 and 110 mg/dL and those at or below 
70  mg/dL  are  hypoglycemic  and  those  at  or  above  180  mg/dL  are  hyperglycemic  [3,6].  Glucose 
solutions were prepared to model normal, hyperglycemic, and hypoglycemic conditions. A 50 mM  
2-(Cyclohexylamino)ethanesulfonic acid, 100 mM NaCl stock solution (pH = 9) was prepared and  
α-D-Glucose was added to various amounts of the stock solution to make glucose solutions of 0, 50, 
100,  200,  300,  and  500  mg/dL.  The  concentrations  of  the  solutions  were  verified  with  a  Red 
Glucose/Glucose Oxidase Assay Kit. 
2.3. Swelling Ratio Studies 
Tests were performed to characterize and quantify the volume change, both shrinking and swelling, 
of the hydrogel as a function of glucose concentration and time. The swelling ratios were calculated 
using,  
SwellingRatio 
Weighttime
Weightinitial
  (1)  
where Weighttime is the weight of the hydrogel at the time of measurement and Weightinitial is the initial 
weight of the hydrogel (prior to immersion in a solution with a glucose concentration).  
2.3.1. Swelling Study: Swelling Ratio versus Time 
To initialize the hydrogel, a slab was placed in a 0 mg/dL glucose solution for 1 week at 25 ° C. 
Following initialization, the hydrogel was sliced into 12 equal size rectangular pieces (42.5  7.05 mg). 
Each sample was blotted dry, weighed, and assigned to a vial containing 5 mL of a 50, 100, 200,  
or  300  mg/dL  glucose  solution.  The  samples  were  randomly  assigned  to  each  of  the  four 
concentrations. Each sample was monitored over one month and 25 times each sample was taken out Sensors 2011, 11                                       
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of its respective vial, blotted dry, weighed, and returned to its respective vial. As the swelling ratios 
reached equilibrium, the time between measurements began to increase as less change was observed. 
On average prior to the samples reaching equilibrium the time between measurements was 16 h and 
after the sample reached equilibrium this time was increased on average to 59 h. 
2.3.2. Shrinking Study: Swelling Ratio versus Time 
To assess the reversibility of hydrogel swelling, an experiment was performed in which hydrogels 
that had reached their equilibrium swelling ratios at a certain glucose concentration were transferred  
to a 100 mg/dL glucose solution. Specifically, 12 hydrogels (396.63  187.90 mg) that had reached  
an  equilibrium  swelling  ratio  in  a  glucose  solution  of  50  (n  =  3),  100  (n  =  3),  200  (n  =  3),  
or 300 (n = 3) mg/dL  were blotted dry, weighed, and placed in 12  mL of a 100 mg/dL glucose 
solution. Over the course of one month, 11 times the hydrogels were removed from their vials, blotted 
dry, weighed, and returned to their respective vial. This process was performed daily for the first four 
days and performed less frequently as less change was apparent between measurements. 
2.4. Impedance Measurements 
To demonstrate the feasibility of this hydrogel as a glucose sensor, the impedance  through the 
hydrogel was measured in samples exposed to 300 (n = 4) and 500 (n = 4) mg/dL glucose solutions. 
Two  probes  connected  to  a  LCR  meter  were  placed  in  the  hydrogels  repeatedly  at  increasing  
inter-probe distances. For each distance, the magnitude and phase of the impedance was measured.  
2.5. Scanning Electron Microscopy 
In order to examine the microstructure of the hydrogel, scanning electron microscopy (SEM) was 
performed on three samples exposed to glucose concentrations of 0, 100, and 300 mg/dL. A piece of 
the initialized hydrogel was sliced into 3 equal size pieces (52.6  2.3 mg). One piece was placed in a 
vial  containing  a  solution  with  a  0  mg/dL  glucose  concentration,  another  in  100  mg/dL  glucose 
concentration, and a third in 300 mg/dL glucose concentration. The samples were allowed to reach 
their equilibrium swelling ratio over the course of three weeks. Once no change in swelling ratio was 
observed, samples of each of the hydrogels were sliced from the specimen. Each sample was placed 
into a slit holder using cryo adhesive to anchor. The sample holder was plunged into liquid nitrogen 
slush. A vacuum  was pulled  and the sample was transferred to  the Gata  Alto  2,500 pre-chamber 
(cooled to approximately −170 C). After fracturing the sample with a cooled scalpel to produce a  
free-break surface, the sample was sublimated at −85 C for 30 min followed by sputter coating for  
120  s  with  platinum.  The  sample  was  then  transferred  to  the  microscope  cryo-stage  (maintained  
at −130 C) for imaging. The porosity ratios of the hydrogels were calculated using,  
PorosityRatio 
VoidSpace
TotalSpace
  (2)  
where Void Space (pixels) was defined as the porous area of the hydrogel and the Total Space (pixels) 
was defined as the total area of the analyzed specimen. 
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2.6. Diffusivity Measurements 
The diffusivity of 390 Da MW fluorescein isothiocyanate (FITC)  through glucose solution and 
hydrogels  that  had  reached  equilibrium  swelling  upon  exposure  to  100  and  300  mg/dL  glucose 
solutions  was  investigated  using  FRAP.  A  vibratome  was  used  to  slice  hydrogel  samples  with 
thicknesses  of  approximately  250  m.  Non-conjugated  FITC  molecules  were  added  to  the  100  
and 300 mg/dL glucose solutions in which the hydrogel samples were immersed 48 h prior to the start 
of the experiment. The fluorescent samples were viewed with a FluoView 1,000 confocal system 
connected to a TE2000 inverted microscope. The specimens were scanned at a low laser intensity  
of 5% to locate an area of approximate uniform fluorescence. A circular bleaching area (radius = 30 μm) 
was selected and the experiment was conducted with a 488 nm laser and a bleaching intensity of 100% 
at  a  60×   magnification.  Following  bleaching,  the  fluorescent  response  in  the  field  of  view  was 
monitored over time in 23 concentric circles with radii ranging from 4.14 to 62.3 μm for the hydrogel 
samples  and  12.28  to  186.9  μm  for  the  glucose  solution.  Following  bleaching,  the  average  pixel 
intensity of each region of interest (ROI) at various time points was normalized using,  
I(t,r i)Normalized 
I(t,r i) I(t0,r0)
I(t,r) I(t0,r0)
  (3)  
(defined in 1976 by Axelrod  et al.) such that the average intensity within the bleached ROI ranged 
between 0 and 1 [15]. In this equation, I(t,r i)Normalized is the normalized average intensity of the i
th ROI 
at time t, I(t,r i)is the average true intensity of the i
th ROI at time t, I(t0,r 0) is the intensity of the 
center of the bleached area of the sample at time 0, which is defined as the time of bleaching, and 
I (t,r) is the intensity of the infinite reservoir diffusing into the bleached area at time t. 
A COMSOL transient diffusion model was developed using initial intensity  conditions from each 
ROI. For each time point, the initial concentrations observed in each ROI for the hydrogels exposed to 
100 (n = 13) and 300 (n = 7) mg/dL were averaged for each of the samples and modeled in COMSOL. 
This  was  repeated  for  the  initial  d ata  obtained  from  the  glucose  solution.  Different  diffusion 
coefficients were applied to the models and the intensity profiles over each ROI as a function of time 
were  simulated.  For  each  diffusion  coefficient,  the  COMSOL  model  data  was  compared  to  the 
experimental  data  and  the  model  that  minimized  the  sum  of  squared  differences  between  the 
experimental and model data was determined to be the best -fit model. Assumptions applied to the 
FRAP method include: Fickian diffusion is the only mode of mass transport, diffusion only occurs in 
the radial direction, the FITC does not interact with the hydrogel, the photobleaching is an irreversible 
process, and the bleaching process does not alter the structure of the hydrogel.  
In order to quantify the difference betwe en the diffusivity of the 390 Da MW FITC in glucose 
solution and in hydrogels exposed to the 100 and 300 mg/dL glucose solution, the hindrance ratio was 
calculated using, 
HindranceRatio 
DFITC, GLUCOSESOLUTION
DFITC,HYDROGEL
  (4)  
where DFITC,GLUCOSESOLUTION (m
2/s) is the diffusion coefficient for the FITC in the glucose solution, and 
DFITC,HYDROGEL  (m
2/s) is the diffusion coefficient for the FITC in the hydrogel. Sensors 2011, 11                                       
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2.7. Permeability Measurements 
A sample of the hydrogel was initialized in a 0 mg/dL glucose solution for one week and then sliced 
into nine pieces of equal size (26.53  4.4 mg). Each piece was blotted dry, weighed, measured, and 
placed into a 4-mm diameter cylindrical tube. Six of the tubes were filled with 300 mg/dL glucose 
solution, and the other three were filled with 100 mg/dL glucose solution to initiate hydrogel swelling. 
The  ends  of  the  tubes  were  covered  with  parafilm  to  eliminate  evaporation  and  leaking,  and  the 
hydrogels were allowed to swell and form a tight seal. Permeability columns were constructed using 
1/4”-inner-diameter  Tygon
 tubing  attached  vertically  to  a  support  and  each  hydrogel  sample  was 
connected with a liquid tight seal to the bottom of a column. The columns were filled with glucose 
solutions that matched those that the hydrogels were initially exposed to and the initial height of the 
solution  column  and  time  were  recorded.  Over  time,  multiple  measurements  of  the  height  of  the 
column  above  the  hydrogel  were  recorded.  From  these,  the  flow  rate  of  the  liquid  Q  (m
3/s)  was 
obtained and divided by the cross-sectional area of the specimen Am (m
2) to obtain the velocity v (m/s) 
of the liquid. Darcy’s Law was used to calculate the permeability constant for each of the samples,  
v 
Q
A



P
Lm

 

    (5)  
where  is Darcy permeability (m
2), Lm (m) is the length of the specimen, P (Pa) is pressure, and  
 (Pas) is the dynamic viscosity of the fluid. 
3. Results 
3.1. Swelling Ratio 
A plot of the average swelling ratio versus time for each glucose concentration group is shown in 
Figure 1(a). The hydrogels displayed a logarithmic swelling trend over time when transferred from  
a 0 mg/dL glucose solution to one containing 50, 100, 200, or 300 mg/dL glucose. As shown in  
Table  1,  increased  degree  of  hydrogel  swelling  correlated  with  increasing  glucose  concentration. 
Specifically, hydrogels that were transferred from a 0 mg/dL glucose solution to a 50 mg/dL glucose 
solution had the slowest rate of swelling, followed by the hydrogels exposed to 100 mg/dL glucose, 
then those exposed to 200 mg/dL glucose; and finally, the hydrogels exposed to the 300 mg/dL glucose 
solution showed the fastest swelling. The swelling ratios appeared to reach steady state values after 
approximately 300 h of exposure to the glucose solution. Once the hydrogels reached equilibrium, the 
percent polymer was calculated by dividing the initial weight of the polymer by the weight of the 
equilibrated sample; the percent polymer was inversely proportional to the final glucose concentration 
as shown in Table 1. ANOVA ( = 0.05) revealed that there was a statistically significant difference 
between the equilibrium swelling ratios of the hydrogels exposed to 50, 100, 200, and 300 mg/dL 
glucose  concentrations  (p-value  <  0.001).  Post  hoc  analysis  using  Tukey’s  Mean  Comparison  
Test ( = 0.05) revealed that the equilibrium swelling ratio of the hydrogels exposed to a 50 mg/dL 
glucose  solution  was  significantly  different  than  the  equilibrium  swelling  ratios  of  the  hydrogels 
exposed to 100, 200, and 300 mg/dL glucose solutions. It was also determined that the equilibrium 
swelling ratios of the hydrogels exposed to 100 and 200 mg/dL glucose solutions were not statistically Sensors 2011, 11                                       
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different  from  one  another,  however  the  equilibrium  swelling  ratio  of  the  hydrogels  exposed  
to 300 mg/dL glucose solution showed a statistically significant difference from all other groups. 
Figure  1(b)  shows  the  average  equilibrium  swelling  ratio  versus  glucose  concentration.  Linear 
regression was performed for average equilibrium swelling ratio on glucose concentration of exposure. 
For  every  mg/dL  increase  in  glucose  concentration,  there  was  a  resultant  6.0%  increase  in  the 
equilibrium swelling ratio. The coefficient of determination was found to be 0.93. When forcing the 
regression to fit the swelling ratio to 1.0 at a glucose concentration of 0 mg/dL, the coefficient of 
determination was reduced to 0.88 and the equilibrium swelling ratio was found to increase by 7.4% 
for every mg/dL increase in glucose concentration.  
Overall, when the hydrogels were transferred from one glucose concentration to 100 mg/dL they 
behaved as expected. The group initially exposed to a solution of 100 mg/dL glucose served as a 
control. The swelling ratio for each sample and the average swelling ratio for each concentration group 
are plotted in Figure 1(c). The samples that had equilibrated in a 50 mg/dL glucose solution swelled 
significantly  when  placed  in  the  100  mg/dL  glucose  solution,  whereas  the  samples  that  had 
equilibrated  in  a  glucose  solution  of  200  and  300  mg/dL  significantly  shank  when  transferred  to  
the 100 mg/dL glucose solution. As expected, the samples that had already equilibrated to a 100 mg/dL 
glucose solution did not fluctuate in mass substantially when transferred to the new 100 mg/dL glucose 
solution.  Two  hydrogel  samples,  one  from  the  50  mg/dL  glucose  solution  group  and  one  from  
the 300 mg/dL glucose solution group were excluded from the data analysis due to degradation caused 
by the extensive handling required by this study. ANOVA ( = 0.05) revealed there was a statistical 
difference between the equilibrium swelling ratios of the hydrogels that were transferred to 100 mg/dL 
glucose  solution  following  equilibration  in  glucose  solutions  of  50,  100,  200,  and  300  mg/dL  
(p-value = 0.0114).  
Table 1. Polymer percentage and best-fit trend lines for the swelling ratio versus time for 
hydrogels exposed to 50, 100, 200, and 300 mg/dL glucose solutions. 
Glucose 
Concentration 
(mg/dL) 
Average 
Equilibrium 
Swelling Ratio 
Best-Fit Equation 
Coefficient  of 
Determination 
(R
2) 
Polymer 
Percentage 
50  4.88  SR = 0.5307ln(GC) + 1 0.73  32.2  27.8 
100  12.28  SR = 1.5695ln(GC) + 1 0.82  8.2  0.5 
200  15.88  SR = 1.9614ln(GC) + 1 0.84  6.3  0.6 
300  21.66  SR = 3.0425ln(GC) + 1 0.83  4.6  0.1 
       GC: Glucose concentration of exposure 
       SR: Equilibrium swelling ratio. 
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Figure  1.  (a)  Swelling  ratio  versus  time  for  hydrogel  samples  that  were  exposed  
to glucose solutions of 50, 100, 200, and 300 mg/dL after initially being placed in 0 mg/dL 
glucose  solution.  Equilibrium  was  reached  after  approximately  300  h.  (b)  Equilibrium 
swelling ratio of the hydrogels versus glucose concentration of exposure. (c) Swelling ratio 
versus time of hydrogels that had reached equilibrium swelling ratios in 50, 100, 200,  
and 300 mg/dL glucose solutions and then transferred to a glucose solution with a glucose 
concentration of 100 mg/dL. (d) Impedance versus distance through hydrogels that were 
exposed to 300 and 500 mg/dL glucose solutions. 
 
3.2. Impedance 
For  all  values,  the  phase  angle  remained  between  −3  and  −8° ,  indicating  a  largely  resistive 
impedance.  As  shown  in  Figure  1(d),  for  the  hydrogels  exposed  to  300  and  500  mg/dL  glucose 
solutions,  the  magnitude of the impedance increased  linearly with  distance with an average  slope  
of 47 Ω/mm (R
2 = 0.95). The average slope of the best-fit lines for impedance versus distance for 
hydrogels exposed to 300 and 500 mg/dL glucose solutions were 44 Ω/mm (R
2 = 0.96) and 49 Ω/mm 
(R
2 = 0.97), respectively.  
3.3. Scanning Electron Microscopy 
SEM images were imported into Image-Pro Plus 5.1 to compare the porosity of the hydrogels that 
were exposed to 0, 100, and 300 mg/dL glucose solutions (Figure 2). The ratio of the void space to the Sensors 2011, 11                                       
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total  sample  area  was  determined  for  the  hydrogels  exposed  to  0  (n  =  10),  100  (n  =  10),  and  
300 (n = 18) mg/dL glucose solutions. As expected, as glucose concentration increased, pore size 
increased as shown in Table 2; the hydrogels that were exposed to a solution containing 0 mg/dL 
glucose  did  not  have  visible  pores,  therefore  for  these  samples  pore  size  was  assumed  to  be 
approximately zero. An unpaired t-test ( = 0.05) analysis of the SEM images revealed that the ratio of 
the void space to total hydrogel sample area for the hydrogels exposed to 100 and 300 mg/dL glucose 
solutions  were  statistically  significantly  different  from  one  another  (p-value  <  0.0001).  The  95% 
confidence intervals for the porosity ratios for the hydrogels exposed to 100 and 300 mg/dL glucose 
solutions were (0.2604, 0.3085) and (0.3511, 0.3918), respectively.  
Figure 2. SEM images converted to black (hydrogel) and white (pore) scale (50000× ) of the 
hydrogels in various glucose concentrations. (a) 0 mg/dL, (b) 100 mg/dL, (c) 300 mg/dL. 
 
 
3.4. Diffusivity 
To  demonstrate  the  FRAP  procedure,  images  were  taken  of  a  sample  of  hydrogel  before 
photobleaching,  immediately  after  photobleaching,  and  15  min  and  30  min  after  photobleaching 
[Figure 3(A)]. The diffusion coefficients for the FITC in the hydrogels exposed to 100 and 300 mg/dL 
glucose solutions were determined and the results are summarized in Table 2 and Figure 3(B). An 
unpaired t-test ( = 0.05) analysis of the diffusion coefficients for FITC through the hydrogels exposed 
to  100  and  300  mg/dL  glucose  solution  showed  they  were  statistically  significantly  different  
(p-value  =  0.0003).  The  95%  confidence  intervals  for  the  diffusion  coefficients  for  the  hydrogels 
exposed to 100 and 300 mg/dL glucose solutions are (6.19 ×  10
−14 m
2/s , 1.24 ×  10
−13 m
2/s ) and  
(1.79 ×  10
−13 m
2/s, 6.50 ×  10
−13 m
2/s), respectively. The effectiveness of the numerical model was also 
demonstrated  in  Figure  3(B).  The  average  diffusivity  of  FITC  in  free  solution  was  found  to  
be 6.2 ×  10
−10 m
2/s (standard deviation=1.3 ×  10
−10 m
2/s), which is similar to published values for 
glucose in water (6.0 ×  10
−10 m
2/s), thus validating the method [16]. The diffusivity of the FITC in the 
hydrogel exposed to 300 mg/dL glucose solution was approximately 4 orders of magnitude slower than 
the diffusivity of the FITC in glucose solution. The hindrance ratios for the hydrogels exposed to  
the 100 and 300 mg/dL glucose solutions were found to be 6.7 ×  10
3 and 1.5 ×  10
3, respectively. Sensors 2011, 11                                       
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Figure 3. (A) (a) Initial fluorescent sample. (b) Sample immediately following bleaching. 
(c) Sample 15 min after bleaching. (d) Sample 30 min after bleaching. (B) Normalized 
average intensity versus radius for experimental and model data of hydrogels exposed to 
100  and  300  mg/dL  glucose  solution  at  time  points  of  0  and  30  minutes  following 
photobleaching. The hydrogel exposed to the 300 mg/dL glucose solution exhibited faster 
recovery after 30 min following photobleaching than the hydrogel exposed to 100 mg/dL 
glucose solution. 
 
3.5. Permeability 
Using Equation 5 the average permeability of the samples exposed to 100 and 300 mg/dL glucose 
solution over ten days was determined (Table 2). An unpaired t-test ( = 0.05) analysis revealed no 
statistical difference (p-value = 0.5235) between the permeability of the hydrogels exposed to 100 and 
300  mg/dL  glucose  solutions.  The  95%  confidence  interval  for  the  permeability  of  the  hydrogels 
exposed  to  the  100  and  300  mg/dL  glucose  solution  are  (1.68  ×   10
−17 m
2,  8.83  ×   10
−17 m
2)  and  
(4.74 ×  10
−17 m
2, 6.87 ×  10
−17 m
2), respectively. The uncertainty in the calculation is 3.27 ×  10
−18 m
2. 
The permeability was measured over a pressure range of 8,000 to 9,000 Pa.  
Table 2. Porosity ratio, diffusion coefficient, permeability of hydrogels exposed to 100  
and 300 mg/dL glucose solution. 
Glucose 
Concentration 
(mg/dL) 
Porosity Ratio    Diffusion Coefficient    Permeability 
n  Average  CV    n 
Average 
×  10
−14 m
2/s 
CV    n 
Average 
×  10
−17 m
2  CV 
100  10 0.284  0.120   13 9.3  0.6    3  5.26  0.03 
300  18 0.371  0.111   7  41.4  0.6    6  5.80  0.02 
          CV: Coefficient of variance. 
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4. Discussion 
This preliminary characterization demonstrates the potential for using a glucose-sensitive hydrogel 
as the basis for an in vivo, continuous glucose sensor. The ability to relate glucose concentration to the 
volume  and  impedance  change  of  the  hydrogel  was  demonstrated.  There  is  a  direct  relationship 
between the glucose concentration to which the hydrogel was exposed and the equilibrium swelling 
ratio and swelling rate of the hydrogel. It was found that higher glucose concentrations resulted in 
higher  equilibrium  swelling  ratios  and  faster  swelling  rates.  Statistical  analysis  using  ANOVA  
( = 0.05) and a post-hoc Tukey’s Mean Comparison Test ( = 0.05) revealed that all equilibrium 
swelling ratio groups were statistically significantly different from one another except the hydrogels 
exposed  to  100  and  200  mg/dL  glucose  solutions.  The  results  suggest  that  with  optimization  of 
hydrogel  dimensions  and  chemistry  to  increase  the  hydrogel’s  sensitivity  and  response  time,  it  is 
feasible that this hydrogel could be used as a main component of a glucose-sensing device that uses 
Micro-Electro-Mechanical Systems (MEMS) technology. 
For  this  monitoring  application,  it  is  critical  that  the  hydrogel  swelling  responds  to  changing 
glucose concentrations. This behavior was examined in the second study, and ANOVA ( = 0.05) 
revealed there was a statistical difference between the equilibrium swelling ratios of the hydrogels that 
were transferred to 100 mg/dL glucose solution following equilibration in glucose solutions of 50, 100, 
200, and 300 mg/dL. Therefore, the swelling process is reversible and the binding and unbinding of 
glucose from the sensing moiety is effective and quantifiable. 
In addition to glucose concentration, the gel volume is dependent on temperature and ionic strength, 
and these factors can vary throughout the course of a day or from day to day. For example, core body 
temperature can vary by 1 C [17] and normal sodium levels range from 135–147 mmol/L [18]. To 
compensate for these cross-sensitivities, we propose collecting data points from two sets of electrodes. 
The gel between the first set of electrodes will be glucose-sensitive. The gel between the second set of 
electrodes will be identical in every way to the first, with the exception that it will lack sensitivity to 
glucose. Thus, the two measurements can be calibrated so as to extract the volume change due to 
glucose alone. 
Some notable limitations were present due to the nature of the swelling ratio studies. First, multiple 
weight measurements were required, which resulted in the frequent handling of the hydrogels. Despite 
using extreme caution, small bits of the hydrogel were likely lost over time, and second, inconsistent 
manual drying prior to each weighing may also have contributed to the deviations in swelling ratio.  
A  practical  limitation  was  observed  in  the  time  it  takes  the  hydrogels  to  reach  their  
equilibrium swelling ratio. The target response time for continuous glucose monitors is approximately 
5 min to facilitate timely insulin administration [8]. Upon exposure to a higher glucose concentration, 
the hydrogel took approximately 300 h to reach its equilibrium swelling ratio and upon exposure to a 
lower glucose concentration, the hydrogel took almost 600 h to reach its equilibrium swelling ratio. 
The  fact  that  the  shrinking  of  the  hydrogel  took  longer  than  the  swelling  was  also  observed  by 
Matsumoto et al. [19]. However, it is important to note that samples with large dimensions, on the 
order  of  centimeters,  were  used  in  this  study  in  order  to  increase  the  accuracy  of  the  weight 
measurements. In a clinical application of the hydrogel as a glucose sensor, the size of the hydrogel 
would be on the order of micrometers. It is hypothesized that samples with smaller dimensions would Sensors 2011, 11                                       
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reach their equilibrium swelling ratio quicker than the larger hydrogels in this study. In particular, 
diffusive length scales are governed by the Fourier Number for mass transport, F0 
Dt
L
2 , where D is 
the diffusivity, t is the characteristic timescale, and L is the largest diffusive length. Based on the 
experimental data described herein, dimensional analysis indicates that a sample of the hydrogel whose 
largest dimension was no more than 170 μm would reach its equilibrium swelling ratio within the 
proscribed five minutes. The kinetics of the volume changes of hydrogels in general are governed by 
diffusion-limited transport of the glucose solution through the polymeric network, the completion time 
for which is inversely proportional to the square of the smallest dimension of the hydrogel [20]. The 
presented results warrant future optimization of the hydrogel’s dimensions to ensure a timely response 
for use in sensors. 
In order to acquire a quantifiable electrical signal that responds to the change in volume of the 
hydrogel, the impedances through the hydrogels exposed to 300 and 500 mg/dL glucose solutions were 
measured. An insignificant difference between the impedance versus distance plots was observed in 
the hydrogels exposed to 300 and 500 mg/dL glucose solutions. It was concluded that the impedance 
of the hydrogel does not depend on the glucose concentration of exposure; it depends solely on the 
thickness of the hydrogel sample. From the swelling ratio study, it was determined that the hydrogel is 
less than 10% polymer if it is exposed to a glucose concentration above 100 mg/dL and the impedance 
was also independent of the small changes in polymer density with swelling. Thus, the impedance is 
solely dependant on the ions in the solution that diffuse and permeate through the hydrogel. In an  
in vivo setting, the sensor will function similarly by measuring the impedance across a volume of ionic 
fluid,  with  the  interprobe  distance  defined  by  a  hydrogel  that  has  swollen  with  respect  to  the 
surrounding glucose concentration. In future designs, the impedance of the blood will need to be taken 
into account when examining the impedance of the hydrogel due to swelling as a result of glucose. 
This  is  because  the  impedance  of  the  blood  may  vary  depending  on  the  fluctuation  in  the  ionic 
concentration. In order to compensate for this in a future design, an additional calibration component 
may be added that would solely measure the impedance of the surrounding medium.  
Determining the mass transfer properties of the hydrogel is essential in order to be able to model the 
hydrogel’s performance as a sensor, thus we investigated the porous structure of the hydrogel, the 
diffusivity of a small molecule within the hydrogel as a function of glucose concentration, and the 
permeability  of  the  hydrogel  in  a  normal  and  pathological  glucose  solution.  Only  two  glucose 
concentrations were examined due to the fact that a clear trend was apparent between the hydrogels 
exposed to the 100 and 300 mg/dL glucose solution, as shown in Table 2. For these experiments an 
unbalanced design was used, as data was not excluded from additional experiments performed with 
some concentration groups. This fact has been taken into account into the statistical analysis with the 
unpaired t-test (α = 0.05). 
Analysis of the SEM images revealed that there was a statistically significant difference between 
the  ratio  of  the  void  space  to  total  hydrogel  sample  area  for  the  hydrogels  exposed  to  100  and  
300 mg/dL glucose solutions. Upon examination of the images it is evident that the hydrogels exposed 
to the 300 mg/dL glucose solution had more void space when compared to the hydrogels exposed to 
the 100 mg/dL glucose solutions, as shown in Table 2. This significant difference was expected based 
on the swelling ratio study previously described, in which the hydrogels exposed to the 300 mg/dL Sensors 2011, 11                                       
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glucose  solutions  had  a  lower  polymer  percentage  than  the  hydrogels  exposed  to  the  100  mg/dL 
glucose solutions. 
To  estimate  the  diffusivity  of  glucose  (molecular  weight  180  g/mol)  within  the  hydrogel  after 
reaching an equilibrium swelling ratio in glucose solutions of 100 and 300 mg/dL the fluorophore  
non-conjugated FITC with a molecular weight of 390 g/mol was used. It was found that the diffusion 
coefficient of the FITC through the hydrogels exposed to 300 mg/dL glucose solution was larger than 
the diffusion coefficient of the FITC through the hydrogels exposed to 100 mg/dL glucose solution by 
a factor of 4.45. This result was hypothesized as the hydrogels exposed to 100 mg/dL glucose solutions 
have  a  smaller  porosity  ratio  than  the  300  mg/dL.  An  unpaired  t-test  analysis  of  the  diffusion 
coefficients for FITC through the hydrogels exposed to 100 and 300 mg/dL glucose solution showed 
the  difference  was  statistically  significant.  Furthermore,  the  diffusion  coefficient  of  the  FITC  
in 300 mg/dL glucose solution, 6.2 ×  10
−10 m
2/s, was remarkably similar to what has been found for 
glucose in water 6.0 ×  10
−10 m
2/s [16]. This finding not only showed that the diffusivity of the FITC in 
the hydrogels exposed to 100 and 300 mg/dL glucose solutions was 3 to 4 orders of magnitude slower 
than the diffusivity of the FITC in glucose solution, it also added confidence to the validity of the 
experimental  method. The hindrance  ratios showed that the  presence of the hydrogels  slowed  the 
diffusion  of  the  FITC molecules  by  over three  orders  of  magnitude  compared  to  the  diffusion  in 
glucose solution.  
Other studies in the literature have used the permeability constant to infer information about the 
microstructure  of  gels  and  a  sense  of  the  order  of  magnitude  of  the  permeability  of  the  
glucose-sensitive  hydrogel  can  be  gathered  upon  comparison  to  these  findings  (Table  3).  The 
hydrogels exposed to 100 and 300 mg/dL glucose solutions were found to have average permeabilities 
of 5.26 ×  10
−17 m
2 and 5.8 ×  10
−17 m
2, respectively, which were found to be similar to the published 
permeability values of 2, 4, and 7.5% agarose gels [21,22]. Furthermore, an unpaired t-test ( = 0.05) 
analysis revealed no statistical difference between the permeabilities of the hydrogels exposed to 100 
and 300 mg/dL glucose solutions. 
The  pressures  the  hydrogels  were  exposed  to  in  the  permeability  columns  ranged  from  8,000  
to 9,000 Pa (60–67.5 mmHg). As a comparison, the mean arterial pressure of a normal individual is  
83 mmHg and the blood pressure is highest (110 mmHg) in the aorta during systole and is the lowest  
(70 mmHg) during diastole [23]. Furthermore, the mean pressures observed in the pulmonary artery 
and right atrium in normal individuals are 17  2 and 6  5 mmHg, respectively [24,25]. The pressures 
that the hydrogel were exposed to were slightly lower than that of normal mean arterial pressures, but 
higher than those observed in the rest of the circulatory system.  
Future  mathematical  modeling  will  be  performed  using  the  diffusivity  and  permeability  values 
found to test numerous designs of the hydrogel to determine which allows for the fastest diffusion of 
glucose throughout the entire hydrogel, and therefore the quickest response time. To take the modeling 
one step further, the sensor will be modeled in the bloodstream and attached to a stent. 
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Table 3. Comparison of published permeability values with the permeability of hydrogels 
exposed  to  100  and  300  mg/dL  glucose  solutions,  which  resulted  in  4.6%  and  8.2% 
glucose-sensitive hydrogels, respectively. 
Material  Permeability (nm
2) 
7.5% Agarose [21]  22.2 
4% Agarose [22]  41.0 
4.6% Glucose-Sensitive Hydrogel  52.6 
8.2% Glucose-Sensitive Hydrogel  58.0 
2% Agarose [21]  616.0 
Human Vertebral Body (Transverse Direction) [26]  3.59 ×  10
9 
5. Conclusions  
Incremental advances in diabetes research have made a long-term, continuous glucose monitoring 
system  feasible  within  the  near  future.  We  aim  to  develop  a  long-term,  continuous,  intravascular 
glucose monitoring system that will minimize complications due to missed glucose measurements and 
aid in the management of the disease. The ideal intravascular continuous glucose sensor would last for 
the  lifetime  of  the  patient  and  have  a  response  time  and  accuracy  equal  to  the  ex  vivo  glucose 
monitoring systems (<5 seconds and an accuracy in accordance to  ISO 15197 which states blood 
glucose meters must provide results that are within 20% of a laboratory standard 95% of the time)[27]. 
Subcutaneous glucose sensors have a response time of 5–20 minutes due to the lag between the blood 
and interstitial glucose levels [8], their accuracy is of great debate, and the sensor lifetime has been 
found  to  be  only  a  week  due  to  encapsulation  and  sensor  drift  [28,29].  Much  work  needs  to  be 
performed  to  bring  our  future  glucose  sensor  to  these  performance  standards.  However,  these 
preliminary results show this may be possible in the future, thus providing a superior technology to 
continuous  subcutaneous  glucose  sensors.  Preliminary  characterization  of  the  glucose-sensitive 
hydrogel has been performed and the results will be used to model an optimal glucose sensor design. It 
can be concluded that the swelling ratio and rate of the hydrogel are directly related to the glucose 
concentration of exposure. Furthermore, the swelling behavior was determined to be reversible. From 
this swelling behavior, the impedance of the hydrogel can be measured as a function of hydrogel 
thickness, however no dependence on glucose concentration of exposure was observed. It was found 
that the porosity and diffusivity of the hydrogel increase with an increase in the glucose concentration 
of  exposure,  however  an  insignificant  difference  in  the  permeability  of  the  hydrogel  between 
exposures to 100 and 300 mg/dL glucose solutions was observed. Based on these experiments, it seems 
feasible  that  a  continuous,  intravascular  glucose  sensor  could  be  developed  with  the  underlying 
concept that the binding of glucose with the hydrogel results in a volume change, which results in a 
measurable  change  in  impedance  that  is  correlated  to  glucose  concentration.  We  have  gathered 
preliminary data to move forward to optimize and build a prototype of a glucose sensor with this 
hydrogel  and  integrate  it  with  our  previous  work  of  using  FDA-approved  stents  as  antennas  for 
wireless data transfer from within the body [9,30-32].  
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